Abstract
伊赫亚,赵秸米,梁晓峰,Teo Yik Ying.新加坡新型冠状病毒疫苗免疫接种策略研究[J].Chinese journal of Epidemiology,2022,43(3):310-314
新加坡新型冠状病毒疫苗免疫接种策略研究
Research on COVID-19 vaccination strategies in Singapore
Received:November 25, 2021  
DOI:10.3760/cma.j.cn112338-20211125-00919
KeyWord: 新型冠状病毒  免疫接种  防控措施  新加坡
English Key Word: 2019-nCoV  Vaccination  Prevention and control  Singapore
FundProject:2021年中国科协“一带一路”国际科技组织合作平台建设项目(2021ZZGJB0522)
Author NameAffiliationE-mail
Yi Heya Chinese Preventive Medicine Association, Beijing 100021, China  
Zhao Jiemi Chinese Preventive Medicine Association, Beijing 100021, China  
Liang Xiaofeng Chinese Preventive Medicine Association, Beijing 100021, China
Kangtai Biological Vaccine Industry Research Institute, Jinan University, Guangzhou 510632, China 
liangxf@just.edu.cn 
Teo Yik Ying National University of Singapore, Singapore City 119077, Singapore  
Hits: 4293
Download times: 743
Abstract:
      截至2021年12月31日,新加坡累计报告已有4 758 601人完成至少一剂次新型冠状(新冠)病毒疫苗接种,4 714 655人完成两剂次新冠病毒疫苗接种,2 207 341人完成新冠病毒疫苗加强针接种。本研究通过深入分析新加坡新冠病毒疫苗接种现状,解读新加坡国家疫苗接种计划内容,系统梳理新加坡新冠病毒疫苗上门接种、疫苗接种差异化管理、拒绝接种疫苗者感染新冠病毒后自付医药费等具体措施,为我国新冠病毒疫苗接种工作提供参考。
English Abstract:
      As of December 31, 2021, Singapore reported that 4 758 601 had completed at least one dose of COVID-19 vaccination, 4 714 655 had completed two doses of COVID-19 vaccination, and 2 207 341 had received one booster shot of COVID-19 vaccine. This article analyses the current performance of COVID-19 vaccination in Singapore, interprets the content of Singapore's National Vaccination Programme, and systematically introduces specific measures of COVID-19 vaccination in Singapore, such as door-to-door vaccination, vaccination differentiated management, and self-payment of medical expenses for those who refuse to be vaccinated, to provide reference for the COVID-19 vaccination in China.
View Fulltext   Html FullText     View/Add Comment  Download reader
Close